Related references
Note: Only part of the references are listed.Therapeutic Approaches for the No-Option Refractory Angina Patient
Thomas J. Povsic et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2021)
Refractory Angina From Pathophysiology to New Therapeutic Nonpharmacological Technologies
Guglielmo Gallone et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Autologous CD34(+) cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
Timothy D. Henry et al.
EUROPEAN HEART JOURNAL (2018)
Vascular endothelial growth factor gene transfer therapy for coronary artery disease: A systematic review and meta-analysis
Rong Yuan et al.
CARDIOVASCULAR THERAPEUTICS (2018)
Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris
Juan-Carlos Kaski et al.
CIRCULATION (2018)
Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease Cochrane Systematic Review and Meta-Analysis
Lindsey Anderson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial
Giora Weisz et al.
LANCET (2016)
Predictors of Long-term Clinical Endpoints in Patients With Refractory Angina
Thomas J. Povsic et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Comparison of Transendocardial and Intracoronary CD34+ Cell Transplantation in Patients With Nonischemic Dilated Cardiomyopathy
Bojan Vrtovec et al.
CIRCULATION (2013)
Long-Term Follow-Up Assessment of a Phase 1 Trial of Angiogenic Gene Therapy Using Direct Intramyocardial Administration of an Adenoviral Vector Expressing the VEGF121 cDNA for the Treatment of Diffuse Coronary Artery Disease
Todd K. Rosengart et al.
HUMAN GENE THERAPY (2013)
Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication-Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats
Stephen M. Kaminsky et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)
Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)
Krzysztof Kukula et al.
AMERICAN HEART JOURNAL (2011)
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial
Jens Kastrup et al.
EUROINTERVENTION (2011)
Exercise Capacity and Mortality in Older Men A 20-Year Follow-Up Study
Peter Kokkinos et al.
CIRCULATION (2010)
Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer
M. Hedman et al.
GENE THERAPY (2009)
VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial
Duncan J. Stewart et al.
MOLECULAR THERAPY (2009)
Exercise capacity and mortality in black and white men
Peter Kokkinos et al.
CIRCULATION (2008)
Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction
Jon C. George et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2008)
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction
Emerson C. Penn et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease:: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment
D. J. Stewart et al.
GENE THERAPY (2006)
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease
Shmuel Fuchs et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2006)
Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease
Rasmus Sejersten Ripa et al.
EUROPEAN HEART JOURNAL (2006)
Alteration of splicing signals in a genomic/cDNA hybrid VEGF gene to modify the ratio of expressed VEGF isoforms enhances safety of angiogenic gene therapy
H Amano et al.
MOLECULAR THERAPY (2005)
Direct intramyocardial plasmid vascular endothelial growth factor-A165-gene therapy in patients with stable severe angina pectoris -: A randomized double-blind placebo-controlled study:: The Euroinject One trial
J Kastrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris
MF Rousseau et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
BR Chaitman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial
BR Chaitman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs
PR Whitlock et al.
MOLECULAR THERAPY (2004)
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia -: Phase II results of the Kuopio Angiogenesis Trial (KAT)
M Hedman et al.
CIRCULATION (2003)
Vascular endothelial growth factor in ischemia for vascular angiogenesis
TD Henry et al.
CIRCULATION (2003)
A controlled trial of arthroscopic surgery for osteoarthritis of the knee
JB Moseley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia
DW Losordo et al.
CIRCULATION (2002)
Exercise capacity and mortality among men referred for exercise testing
J Myers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion - Evidence for a dose-dependent effect
RC Hendel et al.
CIRCULATION (2000)
Share Paper
